12-112919432-G-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_016816.4(OAS1):c.1082G>C(p.Arg361Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.676 in 1,609,908 control chromosomes in the GnomAD database, including 373,960 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_016816.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OAS1 | NM_016816.4 | c.1082G>C | p.Arg361Thr | missense_variant | 6/6 | ENST00000202917.10 | NP_058132.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OAS1 | ENST00000202917.10 | c.1082G>C | p.Arg361Thr | missense_variant | 6/6 | 1 | NM_016816.4 | ENSP00000202917.5 |
Frequencies
GnomAD3 genomes AF: 0.749 AC: 113856AN: 152050Hom.: 43821 Cov.: 33
GnomAD3 exomes AF: 0.713 AC: 178945AN: 250988Hom.: 65142 AF XY: 0.703 AC XY: 95325AN XY: 135638
GnomAD4 exome AF: 0.669 AC: 974968AN: 1457740Hom.: 330073 Cov.: 50 AF XY: 0.668 AC XY: 484525AN XY: 725396
GnomAD4 genome AF: 0.749 AC: 113986AN: 152168Hom.: 43887 Cov.: 33 AF XY: 0.751 AC XY: 55855AN XY: 74392
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 94% of patients studied by a panel of primary immunodeficiencies. Number of patients: 89. Only high quality variants are reported. - |
OAS1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 17, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at